FindTrial
Sign In

Demonstration Research on Early Identification, Intervention and Comprehensive Service Technology of TCM for Metabolic Syndrome(Cross-sectional study)

Demonstration Research on Early Identification, Intervention and Comprehensive Service Technology of TCM for Metabolic Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2100005441
Enrollment
Unknown
Registered
2021-12-24
Start date
2021-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

Case series:No

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Diagnostic criteria: Refer to the latest diagnostic criteria for metabolic syndrome published in the 2017 "Guidelines for the Prevention and Treatment of Diabetes in China", as follows: ?Abdominal obesity (central obesity): waist circumference =90 cm in men and =85 cm in women. ?Hyperglycemia: Fasting blood glucose =6.1 mmol/L or 2h blood glucose =7.8 mmol/L after glucose load and/or those who have been diagnosed with diabetes and treated. ?Hypertension: blood pressure =130/85 mmHg and/or those who have been confirmed as hypertension and treated. ? Fasting TG=1.70 mmol/L. ? Fasting HDL-C <1.04 mmol/L. Three or more of the above can be diagnosed. Inclusion criteria: ?Age between 18-90 years old; ?Patients in the Guangdong Provincial Hospital of Traditional Chinese Medicine, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Research Institute, Jiangsu Provincial Hospital of Traditional Chinese Medicine Outpatient, Physical Examination Center, and Inpatient Department; ?The data is complete.

Exclusion criteria

Exclusion criteria: ?Severe heart, liver and kidney dysfunction (serum creatinine clearance rate <30ml/min, alanine aminotransferase =2.5 times the upper limit of normal, total bilirubin =1.5 times the upper limit of normal; chronic cardiac insufficiency, cardiac function classification III and above) ?Patients with malignant tumors ?Patients with new cardio-cerebrovascular diseases in the past six months ?Patients with acute infection ? Pregnant or lactating women; ? Secondary blood lipid, blood pressure, and blood sugar abnormalities ?Type 1 diabetes ? Hyperthyroidism or hypothyroidism ?Take glucocorticoids, contraceptives, weight loss drugs and other drugs that affect weight

Design outcomes

Primary

MeasureTime frame
Hips;BMI;blood pressure;waistline;Main observation syndrome;TCM Physique Identification Scale;Early recognition form;—

Countries

China

Contacts

Public ContactZhenjie Liu
zhenjl@139.com13711758166

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026